Clinical Trial Update: Treatment Perception of QD (Once a Day) Dosed Kaletra (Tablets)

View source ↗

Summary

This clinical trial update reports results from a completed study evaluating once-daily Kaletra (lopinavir/ritonavir) for HIV infection, with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Kaletra (lopinavir)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Human Immunodeficiency Virus Infection | Status: COMPLETED | Results posted: 2013-04-22